Conan MedTech is developing a rapid point-of-care diagnostic test for concussions using a lateral flow device that detects neuronal biomarkers in saliva through highly specific monoclonal antibodies. This technology enables immediate assessment of concussion status on the sidelines, enhancing safety for athletes and military personnel.
Funding
$570K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for diagnosing concussions often rely on subjective assessments and can be time-consuming, requiring specialized equipment and trained personnel. This can lead to delays in diagnosis, particularly in settings like sports fields or military deployments, where immediate evaluation is crucial. The lack of rapid, objective diagnostic tools can compromise the safety and well-being of individuals at risk of head injuries.
Solution
Conan MedTech is developing a rapid, point-of-care diagnostic test for concussions using a saliva-based assay. The test utilizes a lateral flow device incorporating highly specific monoclonal antibodies to detect neuronal biomarkers present in saliva following a head injury. This allows for immediate, objective assessment of concussion status at the point of injury, facilitating timely intervention and appropriate medical management. The portable nature of the device enables its use in diverse settings, from athletic events to military operations, enhancing access to concussion diagnosis.
Target Audience
The primary target audience includes athletes, military personnel, and students, as well as the medical professionals and organizations responsible for their care, such as athletic trainers, team physicians, school nurses, and military medical units.
Features
- Rapid results available within minutes at the point of care
- Non-invasive saliva-based sample collection
- Utilizes highly specific monoclonal antibodies for accurate biomarker detection
- Portable and easy-to-use lateral flow device
- Objective assessment of concussion status, reducing reliance on subjective measures